NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001505

Registered date:03/07/2009

The phase II study of hypo-fractionated proton beam therapy for mucosal melanoma of the head and neck

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedMucosal melanoma of the head and neck
Date of first enrollment2009/07/01
Target sample size35
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Proton beam therapy 60GyE/15fr/5w

Outcome(s)

Primary OutcomeLocal control rate
Secondary OutcomeOverall survival Acute toxicity Late toxicity

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria1.Histologically confirmed mucosal melanoma 2.nasal or paranasal mucosal melanoma 3.N0 and M0 4.PS(ECOG):0-2 5.adequate organ function
Exclude criteria1.with active other carcinoma 2.with mental disorder 3.recieve systemic steroid therapy 4.with active infectious disease

Related Information

Contact

public contact
Name Sadamoto Zenda
Address 6-5-1 Kashiwanoha Kashiwa Chiba Japan
Telephone 04-7133-1111
E-mail szenda@east.ncc.go.jp
Affiliation National Cancer Center Hospital East Division of Radiation Oncology
scientific contact
Name Sadamoto Zenda
Address 6-5-1 Kashiwanoha Kashiwa chiba, Japan Japan
Telephone 04-7133-1111
E-mail szenda@east.ncc.go.jp
Affiliation National Cancer Center Hospital East Division of Radiation Oncology